Alto Neuroscience (Alto Neuroscience) Net Issuance of Preferred Stock : $45.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Alto Neuroscience's net issuance of preferred for the three months ended in Mar. 2024 was $0.00 Mil. The number is 0, which means that Alto Neuroscience has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Alto Neuroscience's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2024 was $45.00 Mil.

Alto Neuroscience Net Issuance of Preferred Stock Historical Data

The historical data trend for Alto Neuroscience's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Net Issuance of Preferred Stock Chart

Alto Neuroscience Annual Data

Trend

Dec21

Dec22

Dec23

Net Issuance of Preferred Stock

31.89

34.26

70.00

Alto Neuroscience Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial			10.04	25.00	-	45.00	-

Alto Neuroscience Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $45.00 Mil.

Alto Neuroscience Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024